You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

folfiri

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • (no location specified)
Oct 24, 2023

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023

Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • (no location specified)
Jul 28, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Metastatic Colorectal Cancer Trial in Hangzhou (FOLFIRI)

Recruiting
  • Metastatic Colorectal Cancer
  • FOLFIRI
  • Hangzhou, Zhejinag, China
    SAHZU
Apr 30, 2022

Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • KRAS Gene Mutation
  • Phoenix, Arizona
  • +6 more
Nov 10, 2022

Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, China
    Chinese PLA General Hospital
May 25, 2023

Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +38 more
Jan 25, 2023

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Germany (Cetuximab, FOLFIRI)

Active, not recruiting
  • Adenocarcinoma of the Colon
  • Adenocarcinoma of the Rectum
  • Bochum, Germany
  • +3 more
Oct 14, 2021

Metastatic Colorectal Cancer, Solid Tumor Trial in Chonam, Gyeonggi-do, Seoul (irinotecan, FOLFIRI)

Completed
  • Metastatic Colorectal Cancer
  • Solid Tumor
  • Chŏnam, Korea, Republic of
  • +5 more
Mar 1, 2022

Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer Trial in France (FOLFIRI, OSE2101)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Amiens, France
  • +27 more
Oct 19, 2021

Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • ctDNA Blood Test
  • +8 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University
Feb 8, 2023

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • (no location specified)
Oct 28, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)

Recruiting
  • Neuroendocrine Carcinomas
  • Amiens, France
  • +26 more
Jan 26, 2022

Metastatic Colorectal Cancer, KRAS Gene Mutation Trial (Onvansertib, Bevacizumab, FOLFIRI)

No longer available
  • Metastatic Colorectal Cancer
  • KRAS Gene Mutation
  • (no location specified)
Jan 18, 2021

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

Gastrointestinal Cancer, Metastatic Trial in Worldwide (BI 905711, FOLFIRI, Bevacizumab)

Recruiting
  • Gastrointestinal Cancer, Metastatic
  • BI 905711
  • +2 more
  • Houston, Texas
  • +3 more
Aug 9, 2022

Colorectal Cancer Metastatic Trial in Ireland, United States (Regorafenib (BAY 73-4506), FOLFIRI, Placebo)

Completed
Has Results
  • Colorectal Cancer Metastatic
  • Regorafenib (BAY 73-4506)
  • +2 more
  • Denver, Colorado
  • +23 more
Dec 10, 2020

Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

Recruiting
  • Solid Tumor
  • +7 more
  • Duarte, California
  • +11 more
Jan 6, 2023

Pancreatic Adenocarcinoma Trial in Providence (FOLFIRI, FOLFIRINOX, TriSalus Infusion System)

Withdrawn
  • Pancreatic Adenocarcinoma
  • FOLFIRI
  • +2 more
  • Providence, Rhode Island
    Roger Williams Medical Center
May 27, 2021

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Advanced Solid Tumors Trial in United States (paclitaxel, FOLFIRI, ABT-165)

Active, not recruiting
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +9 more
Mar 23, 2022

Colorectal Cancer Trial (Cetuximab, mFOLFOX6, FOLFIRI)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 29, 2021

Unresectable Metastatic Colorectal Cancer Trial in Belgium, United States (CYAD-101, FOLFOX, FOLFIRI)

Recruiting
  • Unresectable Metastatic Colorectal Cancer
  • Tampa, Florida
  • +3 more
Nov 19, 2020